Literature DB >> 29737013

Incremental dialysis for preserving residual kidney function-Does one size fit all when initiating dialysis?

Anna T Mathew1, Yoshitsugu Obi2, Connie M Rhee2, Jason A Chou2, Kamyar Kalantar-Zadeh2,3,4.   

Abstract

While many patients have substantial residual kidney function (RKF) when initiating hemodialysis (HD), most patients with end stage renal disease in the United States are initiated on 3-times per week conventional HD regimen, with little regard to RKF or patient preference. RKF is associated with many benefits including survival, volume control, solute clearance, and reduced inflammation. Several strategies have been recommended to preserve RKF after HD initiation, including an incremental approach to HD initiation. Incremental HD prescriptions are personalized to achieve adequate volume control and solute clearance with consideration to a patient's endogenous renal function. This allows the initial use of less frequent and/or shorter HD treatment sessions. Regular measurement of RKF is important because HD frequency needs to be increased as RKF inevitably declines. We narratively review the results of 12 observational cohort studies of twice-weekly compared to thrice-weekly HD. Incremental HD is associated with several benefits including preservation of RKF as well as extending the event-free life of arteriovenous fistulas and grafts. Patient survival and quality of life, however, has been variably associated with incremental HD. Serious risks must also be considered, including increased hospitalization and mortality perhaps related to fluid and electrolyte shifts after a long interdialytic interval. On the basis of the above literature review, and our clinical experience, we suggest patient characteristics which may predict favorable outcomes with an incremental approach to HD. These include substantial RKF, adequate volume control, lack of significant anemia/electrolyte imbalance, satisfactory health-related quality of life, low comorbid disease burden, and good nutritional status without evidence of hypercatabolism. Clinicians should engage patients in on-going conversations to prepare for incremental HD initiation and to ensure a smooth transition to thrice-weekly HD when needed.
© 2018 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2018        PMID: 29737013      PMCID: PMC6035086          DOI: 10.1111/sdi.12701

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  75 in total

1.  Impact of hemodialysis dose and frequency on survival of patients on chronic hemodialysis in Lithuania during 1998-2005.

Authors:  Asta Stankuvienė; Edita Ziginskienė; Vytautas Kuzminskis; Inga Arūnė Bumblytė
Journal:  Medicina (Kaunas)       Date:  2010       Impact factor: 2.430

2.  Role of residual renal function in phosphate control and anemia management in chronic hemodialysis patients.

Authors:  E Lars Penne; Neelke C van der Weerd; Muriel P C Grooteman; Albert H A Mazairac; Marinus A van den Dorpel; Menso J Nubé; Michiel L Bots; Renée Lévesque; Piet M ter Wee; Peter J Blankestijn
Journal:  Clin J Am Soc Nephrol       Date:  2010-10-28       Impact factor: 8.237

3.  Recurrent circulatory stress: the dark side of dialysis.

Authors:  Christopher W McIntyre
Journal:  Semin Dial       Date:  2010 Sep-Oct       Impact factor: 3.455

4.  Let us give twice-weekly hemodialysis a chance: revisiting the taboo.

Authors:  Kamyar Kalantar-Zadeh; Francesco G Casino
Journal:  Nephrol Dial Transplant       Date:  2014-04-29       Impact factor: 5.992

5.  Reaching target hemoglobin level and having a functioning arteriovenous fistula significantly improve one year survival in twice weekly hemodialysis.

Authors:  Sarra Elamin; Hasan Abu-Aisha
Journal:  Arab J Nephrol Transplant       Date:  2012-05

6.  Associates of mortality among peritoneal dialysis patients with special reference to peritoneal transport rates and solute clearance.

Authors:  J A Diaz-Buxo; E G Lowrie; N L Lew; S M Zhang; X Zhu; J M Lazarus
Journal:  Am J Kidney Dis       Date:  1999-03       Impact factor: 8.860

7.  Two-times weekly hemodialysis in China: frequency, associated patient and treatment characteristics and Quality of Life in the China Dialysis Outcomes and Practice Patterns study.

Authors:  Brian Bieber; Jiaqi Qian; Shuchi Anand; Yucheng Yan; Nan Chen; Mia Wang; Mei Wang; Li Zuo; Fan Fan Hou; Ronald L Pisoni; Bruce M Robinson; Sylvia P B Ramirez
Journal:  Nephrol Dial Transplant       Date:  2013-12-08       Impact factor: 5.992

8.  Short-term effects of online hemodiafiltration on phosphate control: a result from the randomized controlled Convective Transport Study (CONTRAST).

Authors:  E Lars Penne; Neelke C van der Weerd; Marinus A van den Dorpel; Muriel P C Grooteman; Renée Lévesque; Menso J Nubé; Michiel L Bots; Peter J Blankestijn; Piet M ter Wee
Journal:  Am J Kidney Dis       Date:  2009-12-05       Impact factor: 8.860

9.  Association of initial twice-weekly hemodialysis treatment with preservation of residual kidney function in ESRD patients.

Authors:  Minmin Zhang; Mengjing Wang; Haiming Li; Ping Yu; Li Yuan; Chuanming Hao; Jing Chen; Kamyar Kalantar-Zadeh
Journal:  Am J Nephrol       Date:  2014-08-23       Impact factor: 3.754

10.  Partial recovery of renal function in black patients with apparent end-stage renal failure due to primary malignant hypertension.

Authors:  S H James; A M Meyers; F J Milne; S G Reinach
Journal:  Nephron       Date:  1995       Impact factor: 2.847

View more
  10 in total

1.  Patient-reported outcomes in a pilot clinical trial of twice-weekly hemodialysis start with adjuvant pharmacotherapy and transition to thrice-weekly hemodialysis vs conventional hemodialysis.

Authors:  Mariana Murea; Benjamin R Highland; Wesley Yang; Emily Dressler; Gregory B Russell
Journal:  BMC Nephrol       Date:  2022-09-27       Impact factor: 2.585

Review 2.  Patient-centred approaches for the management of unpleasant symptoms in kidney disease.

Authors:  Kamyar Kalantar-Zadeh; Mark B Lockwood; Connie M Rhee; Ekamol Tantisattamo; Sharon Andreoli; Alessandro Balducci; Paul Laffin; Tess Harris; Richard Knight; Latha Kumaraswami; Vassilios Liakopoulos; Siu-Fai Lui; Sajay Kumar; Maggie Ng; Gamal Saadi; Ifeoma Ulasi; Allison Tong; Philip Kam-Tao Li
Journal:  Nat Rev Nephrol       Date:  2022-01-03       Impact factor: 42.439

3.  Incremental and Personalized Hemodialysis Start: A New Standard of Care.

Authors:  Massimo Torreggiani; Antioco Fois; Antoine Chatrenet; Louise Nielsen; Lurlynis Gendrot; Elisa Longhitano; Léna Lecointre; Claudine Garcia; Conrad Breuer; Béatrice Mazé; Assia Hami; Guillaume Seret; Patrick Saulniers; Pierre Ronco; Frederic Lavainne; Giorgina Barbara Piccoli
Journal:  Kidney Int Rep       Date:  2022-02-19

4.  Incremental dialysis in ESRD: systematic review and meta-analysis.

Authors:  Carlo Garofalo; Silvio Borrelli; Toni De Stefano; Michele Provenzano; Michele Andreucci; Gianfranca Cabiddu; Vincenzo La Milia; Valerio Vizzardi; Massimo Sandrini; Giovanni Cancarini; Adamasco Cupisti; Vincenzo Bellizzi; Roberto Russo; Paolo Chiodini; Roberto Minutolo; Giuseppe Conte; Luca De Nicola
Journal:  J Nephrol       Date:  2019-01-02       Impact factor: 3.902

5.  Residual renal function in incremental dialysis.

Authors:  James Tattersall
Journal:  Clin Kidney J       Date:  2018-09-11

6.  Benefits of Incremental Hemodialysis Seen in a Historical Cohort Study.

Authors:  Weisheng Chen; Mengjing Wang; Minmin Zhang; Weichen Zhang; Jun Shi; Jiamin Weng; Bihong Huang; Kamyar Kalantar-Zadeh; Jing Chen
Journal:  Ther Clin Risk Manag       Date:  2021-11-13       Impact factor: 2.423

Review 7.  Novel options for failing allograft in kidney transplanted patients to avoid or defer dialysis therapy.

Authors:  Ekamol Tantisattamo; Ramy M Hanna; Uttam G Reddy; Hirohito Ichii; Donald C Dafoe; Gabriel M Danovitch; Kamyar Kalantar-Zadeh
Journal:  Curr Opin Nephrol Hypertens       Date:  2020-01       Impact factor: 3.416

Review 8.  Intradialytic Nutrition and Hemodialysis Prescriptions: A Personalized Stepwise Approach.

Authors:  Giorgina Barbara Piccoli; Francoise Lippi; Antioco Fois; Lurlynis Gendrot; Louise Nielsen; Jerome Vigreux; Antoine Chatrenet; Claudia D'Alessandro; Gianfranca Cabiddu; Adamasco Cupisti
Journal:  Nutrients       Date:  2020-03-16       Impact factor: 5.717

9.  Combining Peritoneal and Hemodialysis in the Same Patient: Furthering Precision Medicine in Dialysis Transitions.

Authors:  John Sy; Kamyar Kalantar-Zadeh
Journal:  Kidney Int Rep       Date:  2020-02-06

10.  A mixed-method feasibility study of a novel transitional regime of incremental haemodialysis: study design and protocol.

Authors:  Adil M Hazara; Victoria Allgar; Maureen Twiddy; Sunil Bhandari
Journal:  Clin Exp Nephrol       Date:  2021-06-08       Impact factor: 2.801

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.